UNION CITY, Calif.,
Oct. 22, 2015 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company
manufacturing point-of-care instruments and consumables for the
medical, research, and veterinary markets worldwide, announced
today that a co-marketing and technology partnership has been
reached with Vetter Software, which names Vetter Software's cloud
veterinary practice management solution as Abaxis' preferred
practice management solution.
As part of the partnership, Abaxis will co-market and re-sell
Vetter Software's solution globally. The integration between
the companies' products automatically imports results from Abaxis'
blood analyzers into a clinic's Vetter Software account, which
significantly reduces the amount of time spent by clinic staff to
manually import results into a patient's records.
"Cloud technology is disrupting every aspect of veterinary
diagnostics," said Sagi Solomon,
Chief Executive Officer and Founder of Vetter Software. "Veterinary
Hospitals are demanding that data from every aspect of their
practices be available to them in real-time from anywhere.
Our partnership with Abaxis answers this call by leveraging the
power of the cloud to make blood results from Abaxis on-site
analyzers available to practitioners in their Vetter Software
accounts, which can be accessed from any device with an Internet
connection."
Abaxis' Vice President of Sales and Marketing, Dr. Craig Tockman states "The point-of-care
laboratory is a critical aspect of veterinary practice both
medically and financially. Data management is not only important
for the electronic patient record, but for client communication,
workflow and billing. This agreement allows Abaxis to offer state
of the art cloud based solutions to our chemistry and hematology
customers while providing greater accessibility to view
point-of-care laboratory results on any device. Abaxis customers
can now optimally manage their laboratory, provide optimal client
communication and enhance their workflow while providing the most
accurate and precise results from the best analyzers available in
the market."
"Vetter Software has allowed our burgeoning ophthalmology
practice to run paperless, and with increased efficiency," said Dr.
Patrick McCallum, owner of Vision
Care for Animals, a specialty practice based in Palo Alto, California. "We appreciate the
latest integration with Abaxis, it is keeping our in-house clinical
chemistry results at our fingertips the moment we need it."
About Vetter Software
Vetter Software is the leading
cloud veterinary healthcare company. Our mission is to deliver
innovation that helps coordinate and improve the care and health of
the world's animals. Vetter Software was founded in 2011 and is
based in Santa Clara,
California. To learn more about Vetter Software, please visit
www.vettersoftware.com. Follow us on Twitter @vettersoftware and
like us on Facebook at https://www.facebook.com/VetterSoftware.
About Abaxis
Abaxis, Inc. is a worldwide developer,
manufacturer and marketer of portable blood analysis systems that
are used in a broad range of medical specialties in human or
veterinary patient care to provide clinicians with rapid blood
constituent measurements. Our mission is to improve the
efficiency of care delivery to and the quality of life of patients
in the medical and veterinary markets. We provide leading
edge technology, tools and services that support best medical
practices, enabling physicians and veterinarians to respond to the
health needs of their clients at the point of care while operating
economical and profitable practices. For more information,
visit http://www.abaxis.com.
Forward Looking Statements
This press release
includes statements that constitute "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 (the "Reform Act"), including but not limited to statements
related to Abaxis' cash position, financial resources and potential
for future growth, market acceptance and penetration of new or
planned product offerings, and future recurring revenues and
results of operations. Abaxis claims the protection of the
safe-harbor for forward-looking statements contained in the Reform
Act. These forward-looking statements are often characterized
by the terms "may," "believes," "projects," "expects,"
"anticipates," or words of similar import, and do not reflect
historical facts. Specific forward-looking statements
contained in this press release or in Abaxis' conference call may
be affected by risks and uncertainties, including, but not limited
to, those related to risks related to the transition of its U.S.
medical sales to Abbott, potential excess inventory levels and
inventory imbalances at the company's distributors, losses or
system failures with respect to Abaxis' facilities or manufacturing
operations, the effect of exchange rate fluctuations on
international operations, fluctuations in quarterly operating
results, dependence on sole suppliers, the market acceptance of
Abaxis' products and services, the continuing development of its
products, required United States Food and Drug Administration
clearance and other government approvals, risks associated with
manufacturing and distributing its products on a commercial scale
free of defects, risks related to the introduction of new
instruments manufactured by third parties, risks associated with
competing in the human diagnostic market, risks related to the
protection of Abaxis' intellectual property or claims of
infringement of intellectual property asserted by third parties and
risks related to condition of the United
States economy. Readers should also refer to the
section entitled "Risk Factors" in Abaxis' annual report on Form
10‑K, and subsequently filed quarterly reports on Form 10‑Q filed
with the United States Securities and Exchange Commission.
Forward-looking statements speak only as of the date the statements
were made. Abaxis does not undertake and specifically
disclaims any obligation to update any forward-looking
statements.
Contact:
|
Abaxis,
Inc.
|
Lytham Partners,
LLC
|
|
Clint
Severson
|
Joe Dorame, Robert
Blum and Joe Diaz
|
|
Chief Executive
Officer
|
602-889-9700
|
|
510-675-6500
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abaxis-selects-vetter-software-to-offer-veterinary-practices-a-complete-cloud-based-solution-300164497.html
SOURCE Abaxis, Inc.